Figure 6.
BRGShumanmice show efficient reconstitution of human AML. The kinetics of human CD45+CD33+ AML cells (patients 1 and 2, top and middle panels) and CD34+ AML cells (patient 3; bottom panels) after transplantation into BRGShuman, BRGSNOD, and NGS mice in the peripheral blood (left panels) and the bone marrow (right panels). The proportions of AML cells in the blood were monitored every 2 weeks, followed by the analysis of bone marrow at the final time point. In all 3 experiments, human AML cell chimerism in BRGShuman mice exceeded that in BRGSNOD mice. *P < .05, **P < .01. n.s., not significant.